1-20 of 34
Diana Giannarelli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib or Chemo-Immunotherapy As Second Line Treatment in Waldenstrom Macroglobulinaemia? a Real-Life Multicentre Study

Francesco Autore, Alessandra Tedeschi, Giulia Benevolo, Nicolò Danesin, Diana Giannarelli, Rita Rizzi, Emanuele Cencini, Veronica Mattiello, Isacco Ferrarini, Jacopo Olivieri, Ilaria Del Giudice, Angela Ferrari, Martina Bullo, Bernardo Rossini, Marina Motta, Dario Marino, Idanna Innocenti, Luca Stirparo, Diego Petrilli, Pellegrino Musto, Veronica Peri, Giulia Zamprogna, Stefan Hohaus, Anna Maria Frustaci, Francesco Piazza, Simone Ferrero, Luca Laurenti
Journal: Blood
Blood (2024) 144 (Supplement 1): 3013.
https://doi.org/10.1182/blood-2024-200111
Published: 2024
Journal Articles

Acalabrutinib in High-Risk Chronic Lymphocytic Leukemia Patients Naïve or Previous Treated. a Multicenter Retrospective Observational Real-Life Experience

Idanna Innocenti, Annamaria Tomasso, Diana Giannarelli, Lydia Scarfo, Roberta Murru, Andrea Visentin, Anna Maria Frustaci, Francesca Morelli, Candida Vitale, Antonio Mosca, Alessandro Sanna, Giuliana Farina, Roberta Laureana, Massimo Gentile, Andrea Galitzia, Raffaella Pasquale, Francesco Autore, Jacopo Olivieri, Azzurra Anna Romeo, Marina Deodato, Luca Stirparo, Andrea Corbingi, Vanessa Innao, Francesca Perutelli, Francesca Martini, Paolo Sportoletti, Alberto Fresa, Maria Ilaria Del Principe, Alessandra Tedeschi, Marta Coscia, Paolo Ghia, Luca Laurenti
Journal: Blood
Blood (2024) 144 (Supplement 1): 6798.
https://doi.org/10.1182/blood-2024-203557
Published: 2024
Journal Articles

Comparison of Familial Versus Sporadic Forms of Chronic Lymphocytic Leukemia: An Italian Multicenter Case-Control Study

Alberto Fresa, Idanna Innocenti, Annamaria Tomasso, Candida Vitale, Alessandro Sanna, Anna Maria Frustaci, Andrea Visentin, Azzurra Anna Romeo, Paolo Sportoletti, Annamaria Giordano, Francesca Perutelli, Roberta Murru, Francesca Romana Mauro, Antonio Mosca, Francesca Morelli, Roberta Laureana, Andrea Galitzia, Ilaria Angeletti, Esmeralda Conte, Riccardo Moia, Giovanni Francesco D'Arena, Raffaella Pasquale, Francesco Autore, Jacopo Olivieri, Luca Stirparo, Giulia Benintende, Andrea Corbingi, Maria Ilaria Del Principe, Diana Giannarelli, Alessandra Tedeschi, Marta Coscia, Eugenio Sangiorgi, Dimitar G Efremov, Luca Laurenti
Journal: Blood
Blood (2024) 144 (Supplement 1): 4621.
https://doi.org/10.1182/blood-2024-205215
Published: 2024
Journal Articles

Prevalence of BTK and PLCG2 Mutations in BTK Inhibitor Treated CLL Patients Who Experience Disease Progression: A Meta-Analysis

Stefano Molica, David Allsup, Diana Giannarelli
Journal: Blood
Blood (2024) 144 (Supplement 1): 4630.
https://doi.org/10.1182/blood-2024-200896
Published: 2024
Journal Articles

Targeted Agents in Chronic Lymphocytic Leukemia (CLL): Advancements in Overall Survival Outcomes?

Stefano Molica, Tait D. Shanafelt, David Allsup, Diana Giannarelli
Journal: Blood
Blood (2023) 142 (Supplement 1): 4647.
https://doi.org/10.1182/blood-2023-180699
Published: 2023
Journal Articles

The Integration of Efficacy and Safety Outcomes Identifies the Net Clinical Benefit of Targeted Agents in Upfront Therapy of Chronic Lymphocytic Leukemia: Results of Network Meta-Analysis

Stefano Molica, David Allsup, Aaron Polliack, Diana Giannarelli
Journal: Blood
Blood (2022) 140 (Supplement 1): 9913–9914.
https://doi.org/10.1182/blood-2022-157384
Published: 2022
Journal Articles

A Clue to Better Select Chronic Lymphocytic Leukemia Patients with Optimal Response to BNT162b2 mRNA COVID-19 Vaccine

Stefano Molica, Diana Giannarelli, Mirella Lentini, Daniela Zappala, Daniela Loiacono, Valentina Gianfelici, Giuseppina Panduri, Pasquale Minchella, Francesco Talarico, Luciano Levato
Journal: Blood
Blood (2021) 138 (Supplement 1): 3740.
https://doi.org/10.1182/blood-2021-149104
Published: 2021
Journal Articles

Comparison between Time-Limited,Venetoclax-Based and Continuous Bruton Thyrosine Kinase Inhibitors-Based Therapy in the Upfront Treatment of Chronic Lymphocytic Leukemia (CLL):a Systematic Review and Network Meta-Analysis

Stefano Molica, MD, Diana Giannarelli, PhD, Emili Montserrat, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-137405
Published: 2020
Journal Articles

Upfront Therapy with Ibrutinib Results in a Longer Progression-Free Survival Independently of IGHV Mutational Status and Del(11q) in CLL Patients. Results of a Comprehensive Review and Meta-Analysis

Stefano Molica, MD, Diana Giannarelli, PhD, Luciano Levato, MD, Emili Montserrat, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5469.
https://doi.org/10.1182/blood-2019-123596
Published: 2019
Journal Articles

Real-Rd - Real Life Italian Experience with Lenalidomide and Low-Dose Dexamethasone (Rd) As First Line Treatment of Newly-Diagnosed Multiple Myeloma Patients Not Eligible to Stem Cell Transplantation: Outcomes and Tolerability

Alessandra Pompa, Concetta Conticello, MD, Diana Giannarelli, PhD, Loredana Pettine, MD, Laura Paris, MD, Lucia Tognazzi, Magda Marcatti, MD, Elisabetta Antonioli, MD, Francesca Fioritoni, MD, Angela Bonalumi, MD, Silvia Mangiacavalli, Paola Bertazzoni, Iolanda Donatella Vincelli, MD, Daniele Derudas, MD, Agostina Siniscalchi, Sara Pezzatti, MD, Renato Zambello, Annalisa Citro, MD, Angelo Belotti, Alessandra Lombardo, MD, Federico Vozella, MD, Adelina Sementa, MD, Ugo Consoli, MD, Alfredo Molteni, MD, Niccolò Frungillo, MD, Massimo Gentile, MD, Gabriele Buda, MD PhD, Sara Aquino, Salvatore Palmieri, Velia Bongarzoni, MD, Alessandro Inzoli, MD, Valeria Ferla, MD, Francesca Gaia Rossi, MD, Valerio Leotta, MD, Alessandra Romano, MD PhD, Federica Elia, MD, Vittorio Del Fabro, MD, Guido Montanaro, MD, Francesca Cavallaro, MD, Monica Galli, Luca Baldini, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5555.
https://doi.org/10.1182/blood-2019-125098
Published: 2019
Journal Articles

The Magnitude of Improvement in Progression-Free Survival with Targeted Therapy in Relapsed/Refractory Chronic Lymphocytic Leukemia Based on Genetic Risk: A Systematic Review and Meta-Analysis

Stefano Molica, MD, Diana Giannarelli, PhD, Rosana Mirabelli, MD, Luciano Levato, Tait D. Shanafelt, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5568.
https://doi.org/10.1182/blood-2018-99-112580
Published: 2018
Journal Articles

Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysis

Clinical Trials & Observations
Stefano Molica, Diana Giannarelli, Rosanna Mirabelli, Luciano Levato, Neil E. Kay, Tait D. Shanafelt
Journal: Blood
Blood (2018) 131 (3): 365–368.
https://doi.org/10.1182/blood-2017-09-806034
Published: 2018
Includes: Supplemental data
Journal Articles

Hypogammaglobulinemia in Chronic Lymphocytic Leukemia: A Predictor of Outcome?

Gianluigi Reda, MD, Ramona Cassin, MD, Giorgia Levati, Bruno Fattizzo, MD, Veronica Mattiello, Diana Giannarelli, PhD, Francesco Onida, MD, Wilma Barcellini, MD, Agostino Cortelezzi, Prof
Journal: Blood
Blood (2017) 130 (Supplement 1): 2997.
https://doi.org/10.1182/blood.V130.Suppl_1.2997.2997
Published: 2017
Journal Articles

Real-World Data of Nivolumab in Classical Hodgkin Lymphoma: Results from the Italian Expanded Access Programme

Armando Santoro, MD, Francesco D'alo', MD, Pier Luigi Zinzani, MD, Luigi Rigacci, Francesco Angrilli, Paolo Corradini, MD, Francesco Lanza, MD, Giorgina Specchia, MD, Maria Cantonetti, Nicola Cascavilla, MD, Caterina Patti, MD, Brunangelo Falini, MD, Felicetto Ferrara, Barbara Botto, Catello Califano, Livio Trentin, MD, Marco Gobbi, MD, Anna Vanazzi, MD, Diana Giannarelli, PhD, Antonello Pinto
Journal: Blood
Blood (2017) 130 (Supplement 1): 5171.
https://doi.org/10.1182/blood.V130.Suppl_1.5171.5171
Published: 2017
Journal Articles

Chronic Lymphocytic Leukemia International Prognostic INDEX (CLL-IPI) Predicts Prognosis of CLL: A Systematic Review and Meta-Analysis

Stefano Molica, MD, Diana Giannarelli, PhD, Luciano Levato, MD, Rosana Mirabelli, MD, Tait D. Shanafelt, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1739.
https://doi.org/10.1182/blood.V130.Suppl_1.1739.1739
Published: 2017
Journal Articles

Atrial Fibrillation (AF) and Ibrutinib, a Monocentric Experience: Should Cardiological Evaluation be a Guide in Clinical Practice?

Gianluigi Reda, MD, Ramona Cassin, Veronica Mattiello, Tatiana Tonella, Diana Giannarelli, PhD, Bruno Fattizzo, MD, Francesco Onida, MD, Ferdinando Maria Massari, Agostino Cortelezzi, Prof
Journal: Blood
Blood (2017) 130 (Supplement 1): 1747.
https://doi.org/10.1182/blood.V130.Suppl_1.1747.1747
Published: 2017
Journal Articles

Impact of Bone Marrow Fibrosis and Early Response on Outcome after Azacitidine Therapy in 94 Patients with Myelodisplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia

Gianluigi Reda, MD, Marta Riva, MD, Ramona Cassin, MD, Bruno Fattizzo, MD, Martina Pennisi, MD, Diana Giannarelli, MD, Alfredo Molteni, Alessandra Freyrie, MD, Roberto Cairoli, MD, Agostino Cortelezzi, MD
Journal: Blood
Blood (2016) 128 (22): 3187.
https://doi.org/10.1182/blood.V128.22.3187.3187
Published: 2016
Journal Articles

A Simple Score, Based on Geriatric Assessment, Predicts Survival in Elderly Newly Diagnosed Chronic Lymphocytic Leukemia Patients

Stefano Molica, MD, Diana Giannarelli, PhD, Luciano Levato, MD, Rosanna Mirabelli, MD, Domenico Levato, MD, Mirella Lentini, PhD, Eugenio Piro, MD, Daniela Zappalà, PhD
Journal: Blood
Blood (2016) 128 (22): 2036.
https://doi.org/10.1182/blood.V128.22.2036.2036
Published: 2016
Journal Articles

Is the International Prognostic INDEX for CLL (CLL-IPI) Useful to Predict Time to First Treatment of Patients with EARLY Disease? Results of a Prospective Multicenter Analysis

Stefano Molica, MD, Diana Giannarelli, MD, Luciano Levato, MD, Rosanna Mirabelli, MD, Massimo Gentile, MD, Fortunato Morabito, MD
Journal: Blood
Blood (2015) 126 (23): 498.
https://doi.org/10.1182/blood.V126.23.498.498
Published: 2015
Journal Articles

Exclusion of SERUM Thymidine Kinase Does NOT Reduce the Predictive VALUE of a Comprehensive Prognostic INDEX in Chonic Lymphocytic Leukemia. Results of an External Validation on a Prospective Cohort of Patients with EARLY Disease

Stefano Molica, MD, Diana Giannarelli, MS, Luciano Levato, MD, Mirabelli Rosanna, MD, Massimo Gentile, MD, Fortunato Morabito, MD
Journal: Blood
Blood (2014) 124 (21): 4692.
https://doi.org/10.1182/blood.V124.21.4692.4692
Published: 2014